GoTo Telemed, the nation‘s leading integrated telehealth ecosystem serving over 10 million patients nationwide [4†L52-L53], today announced the launch of its dedicated Pediatric Thyroid Disorders Program, a comprehensive virtual care service designed to address the full spectrum of thyroid conditions in children and adolescents through evidence-based diagnosis, personalized treatment, and ongoing management. Delivered by a network of board-certified pediatric endocrinologists, this program brings expert thyroid care directly to families nationwide, ensuring timely intervention during critical developmental windows.

Thyroid disorders represent some of the most common endocrine conditions in children. Hypothyroidism affects approximately 1 in 2,000 to 1 in 4,000 newborns, with acquired hypothyroidism becoming more common in older children and adolescents [15†L21-L22]. Congenital hypothyroidism (CH) is one of the most common preventable causes of intellectual disability worldwide, resulting from inadequate production of thyroid hormones at birth, which are essential for normal brain maturation and physical growth [7†L10-L13]. Without timely treatment, CH may lead to irreversible neurodevelopmental impairment, growth retardation, and metabolic disturbances [7†L17-L18]. The global incidence ranges from approximately 1 in 2,000 to 1 in 4,000 live births, with regional variability influenced by iodine status and genetic factors [7†L13-L15].

Hyperthyroidism, while less common, affects approximately 1 in 5,000 children and adolescents, with Graves‘ disease accounting for 85-90% of pediatric hyperthyroidism cases, typically presenting in children over 10 years of age with a female-to-male ratio of approximately 5:1 [19†L32-L33][5†L48-L49]. Graves‘ disease in childhood accounts for only 1-5% of all patients with Graves‘ disease but is the cause of more than 95% of cases of pediatric thyrotoxicosis [11†L10-L12]. Early diagnosis requires a high degree of suspicion, as symptoms may appear insidiously over months, including tachycardia, weight loss despite increased appetite, tremor, behavioral changes, and academic decline [11†L14-L17].

“Thyroid disorders in children are not just about hormone levels—they affect growth, cognitive development, academic performance, and lifelong health,” said a GoTo Telemed spokesperson. “For children with congenital hypothyroidism, treatment must begin within the first two weeks of life to prevent permanent neurodevelopmental impairment. For adolescents with Graves‘ disease, prompt diagnosis and treatment can prevent cardiac complications and restore quality of life. Our Pediatric Thyroid Disorders Program brings board-certified pediatric endocrinology expertise directly to families through telehealth, eliminating long wait times and geographic barriers that too often delay critical care.”

Comprehensive Clinical Services Across the Pediatric Thyroid Spectrum

GoTo Telemed‘s Pediatric Thyroid Disorders Program addresses the full range of thyroid conditions in children through specialized clinical pathways aligned with current evidence-based guidelines from the American Academy of Pediatrics (AAP), American Thyroid Association (ATA), European Thyroid Association (ETA), and the Endocrine Society:

Condition Prevalence and Key Facts First-Line Treatment
Congenital Hypothyroidism 1 in 2,000–4,000 newborns; leading preventable cause of intellectual disability; newborns appear clinically normal at birth, making screening essential Levothyroxine 10–15 μg/kg/day initiated before 2 weeks of life; treatment continues at least until age 2–3 years
Acquired Hypothyroidism (Hashimoto‘s Thyroiditis) Most common thyroid disorder in older children; autoimmune cause; prevalence increases with age; female predominance Levothyroxine replacement; target TSH